No abstract available
Keywords:
Body weight; Cardioprotection; Diabetes; GIP receptor agonist; GLP-1 receptor agonist; Incretin; Metabolic disease; Obesity.
MeSH terms
-
Antidotes* / therapeutic use
-
Incretins*
-
Venoms / therapeutic use
Substances
-
Antidotes
-
Incretins
-
Venoms